Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

The patient had a severe allergic reaction to gold treatment.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Belimumab effectively controls SLE disease activity and reduces steroid use.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Platelet-rich plasma speeds up bone healing and reduces complications.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.